Federica Maccarinelli
Brescia, 25123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells.
Journal: Biochemical pharmacology
Published: June 15, 2025
PTX3 shapes profibrotic immune cells and epithelial/fibroblast repair and regeneration in a murine model of pulmonary fibrosis.
Journal: Pathology, research and practice
Published: August 29, 2023
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
Journal: Experimental hematology & oncology
Published: March 16, 2023
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer.
Journal: Pharmacological research
Published: October 24, 2022
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination.
Journal: Experimental hematology & oncology
Published: August 06, 2022
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Journal: Cancer letters
Published: August 03, 2021
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis.
Journal: Free radical biology & medicine
Published: February 20, 2021
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
Journal: European journal of medicinal chemistry
Published: December 09, 2020
Endogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis.
Journal: Frontiers in immunology
Published: October 15, 2020
Last Updated: 09/26/2026